It has been reported that patients with T2DM and COVID-19 have elevated levels of proinflammatory cytokines, such as IL-6 and TNF-α, as well as higher white blood cell counts (such as neutrophils), suggesting a heightened inflammatory response compared to patients without T2DM [209]. This evidence concerns the gene TNF and COVID-19.